Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bill Deakin

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Journal of Psychopharmacology (Oxford, England)|September 5, 2024
Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatinImran B Chaudhry, Muhammad Omair Husain, Ameer B Khoso, et al.
Schizophrenia Research|March 5, 2021
Peripheral immune markers and antipsychotic non-response in psychosisDaniela Enache, Naghmeh Nikkheslat, Dina Fathalla, et al.
Brain, Behavior, and Immunity|May 14, 2023
The association between peripheral inflammation, brain glutamate and antipsychotic response in Schizophrenia: Data from the STRATA collaborationSunniva Fenn-Moltu, Bill Deakin, Richard Drake, et al.
Trials|April 18, 2015
The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trialDanuta M Lisiecka, John Suckling, Thomas R E Barnes, et al.
Human Brain Mapping|March 23, 2011
The Neuro/PsyGRID calibration experiment: identifying sources of variance and bias in multicenter MRI studiesJohn Suckling, Anna Barnes, Dominic Job, et al.
Human Brain Mapping|January 12, 2010
Power calculations for multicenter imaging studies controlled by the false discovery rateJohn Suckling, Anna Barnes, Dominic Job, et al.
Trials|June 21, 2013
Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trialImran B Chaudhry, Nusrat Husain, Mohammad O Husain, et al.
Scientific Reports|March 27, 2023
Genetic risk of depression is different in subgroups of dietary ratio of tryptophan to large neutral amino acidsBence Bruncsics, Gabor Hullam, Bence Bolgar, et al.
Frontiers in Psychiatry|November 15, 2021
Inflamed Mind: Multiple Genetic Variants of <i>IL6</i> Influence Suicide Risk Phenotypes in Interaction With Early and Recent Adversities in a Linkage Disequilibrium-Based Clumping AnalysisJanos Bokor, Sara Sutori, Dora Torok, et al.
Schizophrenia Bulletin Open|August 15, 2024
Add-on Sodium Benzoate and <i>N</i>-Acetylcysteine in Patients With Early Schizophrenia Spectrum Disorder: A Multicenter, Double-Blind, Randomized Placebo-Controlled Feasibility TrialMuhammad Omair Husain, Imran Bashir Chaudhry, Ameer B Khoso, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Journal of Psychopharmacology (Oxford, England)|September 5, 2024
Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatinImran B Chaudhry, Muhammad Omair Husain, Ameer B Khoso, et al.
Schizophrenia Research|March 5, 2021
Peripheral immune markers and antipsychotic non-response in psychosisDaniela Enache, Naghmeh Nikkheslat, Dina Fathalla, et al.
Brain, Behavior, and Immunity|May 14, 2023
The association between peripheral inflammation, brain glutamate and antipsychotic response in Schizophrenia: Data from the STRATA collaborationSunniva Fenn-Moltu, Bill Deakin, Richard Drake, et al.
Trials|April 18, 2015
The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trialDanuta M Lisiecka, John Suckling, Thomas R E Barnes, et al.
Human Brain Mapping|March 23, 2011
The Neuro/PsyGRID calibration experiment: identifying sources of variance and bias in multicenter MRI studiesJohn Suckling, Anna Barnes, Dominic Job, et al.
Human Brain Mapping|January 12, 2010
Power calculations for multicenter imaging studies controlled by the false discovery rateJohn Suckling, Anna Barnes, Dominic Job, et al.
Trials|June 21, 2013
Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trialImran B Chaudhry, Nusrat Husain, Mohammad O Husain, et al.
Scientific Reports|March 27, 2023
Genetic risk of depression is different in subgroups of dietary ratio of tryptophan to large neutral amino acidsBence Bruncsics, Gabor Hullam, Bence Bolgar, et al.
Frontiers in Psychiatry|November 15, 2021
Inflamed Mind: Multiple Genetic Variants of <i>IL6</i> Influence Suicide Risk Phenotypes in Interaction With Early and Recent Adversities in a Linkage Disequilibrium-Based Clumping AnalysisJanos Bokor, Sara Sutori, Dora Torok, et al.
Schizophrenia Bulletin Open|August 15, 2024
Add-on Sodium Benzoate and <i>N</i>-Acetylcysteine in Patients With Early Schizophrenia Spectrum Disorder: A Multicenter, Double-Blind, Randomized Placebo-Controlled Feasibility TrialMuhammad Omair Husain, Imran Bashir Chaudhry, Ameer B Khoso, et al.
Pageof 7